首頁 > 市場調查報告書 > 製藥

生物製劑分子標靶治療學

2030 年亞太地區抗體發現市場預測 - 區域分析 - 按抗體類型、性質、服務和最終用戶

市場調查報告書

商品編碼

1592593

2030 年亞太地區抗體發現市場預測 - 區域分析 - 按抗體類型、性質、服務和最終用戶

Asia Pacific Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type, Nature, Services, and End User

出版日期: 2024年09月16日 | 出版商:

The Insight Partners | 英文 90 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年亞太地區抗體發現市值為65896505萬美元，預計2030年將達到115868186萬美元；預計2022年至2030年複合年成長率為7.3%。

發展中地區生物技術產業的激增推動亞太抗體發現市場

抗體在辨識抗原方面具有極高的精確度，使其成為科學家和臨床醫生的寶貴工具。在現代生物技術中，從基礎研究到創新醫學評估的許多過程都需要抗體。治療性抗體的開發為治療各種疾病開闢了新途徑，證明了這些顆粒的轉化能力。抗體在基於抗體的診斷中也至關重要，因為它們提供了準確可靠的疾病識別方法。政府不斷增加的支持、公私合作夥伴關係的加強、疾病概況的不斷變化以及資助活動的增加正在廣泛提高亞太地區等地區生物技術行業的績效。

根據經濟合作暨發展組織 (OECD) 的數據，截至 2019 年，中國在研發支出方面處於領先地位。亞洲等地區國家政府提供稅收優惠、更便宜的土地和直接投資，鼓勵生技公司擴大產能和增強能力。因此，台灣、馬來西亞、印度、中國、新加坡和日本等國家是生技產業最有利的目的地之一。此外，這些亞洲國家更注重利用基因組學、蛋白質組學和生物標記的進步進行診斷和治療應用。因此，發展中地區生物技術產業的持續擴散預計將在未來幾年為抗體發現市場創造機會。

亞太地區抗體發現市場概況

亞太地區抗體發現市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。 2022年，中國將佔據最大的市場佔有率，而印度預計在預測期內將實現顯著的市場複合年成長率。中國的生物製藥產業正在經歷巨大轉變，從以學名藥為中心的格局演變為蓬勃發展的創新中心。此外，工業化的進步以及新藥、高階醫療器材和技術的應用也有助於中國抗體發現市場的成長。

中國正在經歷心血管疾病和其他慢性病的盛行率激增。根據《生物醫學與環境科學期刊》報道，2021年中國有近3.3億人患有心血管疾病。因此，心臟病的迅速流行引發了對抗體發現的需求。在研究中心的幫助下，可以研究抗體序列，開發新的和新穎的抗體，並最佳化現有的抗體。根據 Scimago Institute 排名，截至 2022 年，中國擁有近 170 個醫學研究中心，其次是日本（72 個）、澳洲（53 個）和印度（17 個）。此外，越來越多的市場參與者專注於亞太地區國家的地理擴張和其他成長策略、研究中心數量的增加以及政府資助的顯著增加，推動了亞太地區抗體發現市場的成長。

亞太地區抗體發現市場收入及 2030 年預測（十億美元）

亞太地區抗體發現市場區隔

亞太地區抗體發現市場按抗體類型、性質、服務、最終用戶和國家分類。

根據抗體類型，亞太地區抗體發現市場分為單株抗體、多株抗體等。 2022 年，單株抗體領域佔據亞太地區最大的抗體發現市場。

就性質而言，亞太地區抗體發現市場分為人類和人源化、嵌合和鼠類。 2022 年，人類和人源化細分市場佔據亞太地區最大的抗體發現市場。

依服務分類，亞太抗體發現市場分為噬菌體展示、雜交瘤、基因改造動物、單細胞和酵母展示。 2022 年，噬菌體展示領域佔據亞太地區最大的抗體發現市場。

根據最終用戶，亞太地區抗體發現市場分為製藥和生技公司、研究實驗室等。 2022 年，製藥和生物技術公司細分市場佔據亞太地區最大的抗體發現市場。

依國家/地區分類，亞太地區抗體發現市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。 2022年，中國在亞太抗體發現市場佔有率中佔據主導地位。

Charles River Laboratories International Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp 和 Biocytogen Pharmaceuticals 北京有限公司是亞太地區抗體發現市場上的一些領先公司。

The remarkable precision of antibodies in identifying antigens makes them invaluable tools for scientists and clinicians. In modern biotechnology, antibodies are required in numerous processes, from basic research to innovative medical evaluations. The development of therapeutic antibodies has opened new avenues in treating various diseases, demonstrating the transformative ability of these particles. Antibodies are also crucial in antibody-based diagnostics as they provide accurate and reliable approaches to disease identification. Growing support from governments, rising public-private partnerships, continuously changing disease profiles, and increasing funding activities are widely enhancing the performance of biotechnology industries in the regions such as Asia Pacific.

As per the Organization for Economic Co-operation and Development (OECD), China was a frontrunner in terms of R&D expenditure as of 2019. Heavy investments encourage the adoption of advanced technologies in the healthcare sector. Governments of countries in regions such as Asia offer tax incentives, cheaper land, and direct investments for encouraging biotechnology companies to expand their capacities and strengthen their capabilities. Thus, countries such as Taiwan, Malaysia, India, China, Singapore, and Japan are among the most advantageous destinations for the biotechnology industries. Furthermore, these Asian countries are more focused on using genomics, proteomics, and biomarker advancements for diagnostic and therapeutic applications. Therefore, the ongoing proliferation of biotechnology industries in developing regions is expected to create opportunities for the antibody discovery market in the coming years.

Asia Pacific Antibody Discovery Market Overview

The Asia Pacific antibody discovery market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China accounted for the largest share of the market in 2022, and India is expected to record a significant CAGR in the market during the forecast period. The biopharmaceutical industry in China is undergoing a tremendous shift, evolving from a generics-focused landscape to a thriving innovation hub. Additionally, progress in industrialization, and the application of novel drugs, high-end medical devices, and techniques contribute to the antibody discovery market growth in China.

China is experiencing an upsurge in the prevalence of cardiovascular disease and other chronic diseases. According to the Journal of Biomedical and Environmental Science, nearly 330 million people from the country suffered from cardiovascular diseases in 2021. Antibody products are crucial for the development of novel therapeutics against cardiovascular diseases. Therefore, a burgeoning prevalence of heart disease triggers the need for antibody discovery. With the help of research centers, antibody sequences can be researched, new and novel antibodies can be developed, and existing antibodies can be optimized. According to the Scimago Institute Ranking, China had nearly 170 medical research centers as of 2022, followed by Japan (72), Australia (53), and India (17). Further, the growing number of market players focusing on countries in Asia Pacific for their geographic expansion and other growth strategies, the rising count of research centers, and a notable increase in government funding fuel the antibody discovery market growth in Asia Pacific.

Asia Pacific Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

Asia Pacific Antibody Discovery Market Segmentation

The Asia Pacific antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the Asia Pacific antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest Asia Pacific antibody discovery market share in 2022.

In terms of nature, the Asia Pacific antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest Asia Pacific antibody discovery market share in 2022.

By services, the Asia Pacific antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest Asia Pacific antibody discovery market share in 2022.

Based on end user, the Asia Pacific antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest Asia Pacific antibody discovery market share in 2022.

Based on country, the Asia Pacific antibody discovery market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific antibody discovery market share in 2022.

Charles River Laboratories International Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the Asia Pacific antibody discovery market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Antibody Discovery Market - Key Market Dynamics

4.1 Asia Pacific Antibody Discovery Market - Key Market Dynamics
4.2 Market Drivers
- 4.2.1 Increasing Investments in Research & Development
- 4.2.2 Rising Incidence of Cancer
4.3 Market Restraints
- 4.3.1 High Cost of Production
4.4 Market Opportunities
- 4.4.1 Proliferation of Biotechnology Industry in Developing Regions
4.5 Future Trends
- 4.5.1 Developments for Custom Antibodies
4.6 Impact of Drivers and Restraints:

5. Antibody Discovery Market - Asia Pacific Market Analysis

5.1 Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. Asia Pacific Antibody Discovery Market Analysis - by Antibody Type

6.1 Overview
6.2 Monoclonal Antibodies
- 6.2.1 Overview
- 6.2.2 Monoclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
- 6.3.1 Overview
- 6.3.2 Polyclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Antibody Discovery Market Analysis - by Nature

7.1 Overview
7.2 Human and Humanized
- 7.2.1 Overview
- 7.2.2 Human and Humanized: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
- 7.3.1 Overview
- 7.3.2 Chimeric: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
- 7.4.1 Overview
- 7.4.2 Murine: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Antibody Discovery Market Analysis - by Services

8.1 Overview
8.2 Phage Display
- 8.2.1 Overview
- 8.2.2 Phage Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
- 8.3.1 Overview
- 8.3.2 Hybridoma: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
- 8.4.1 Overview
- 8.4.2 Transgenic Animal: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
- 8.5.1 Overview
- 8.5.2 Yeast Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
- 8.6.1 Overview
- 8.6.2 Single Cell: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Antibody Discovery Market Analysis - by End User

9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 Research Laboratories: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Antibody Discovery Market - Country Analysis

10.1 Asia Pacific Antibody Discovery Market, Revenue and Forecast to 2030
- 10.1.1 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 China
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 China: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.1.4 China: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.1.5 China: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.1.6 China: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.2 Japan
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Japan: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.2.5 Japan: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.2.6 Japan: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.3 India
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 India: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.3.4 India: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.3.5 India: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.3.6 India: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.4 Australia
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Australia: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.4.5 Australia: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.4.6 Australia: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.5 South Korea
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 South Korea: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.6 Rest of Asia Pacific
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.6.4 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.6.5 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.6.6 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Charles River Laboratories International Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 BioDuro LLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sartorius AG
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Aragen Life Sciences Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Twist Bioscience Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Biocytogen Pharmaceuticals Beijing Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 16. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 17. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 18. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 19. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 20. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 21. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 22. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 23. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 24. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 25. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 26. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market

List Of Figures

Figure 1. Asia Pacific Antibody Discovery Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 4. Asia Pacific Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 5. Monoclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Polyclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 9. Human and Humanized: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Chimeric: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Murine: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 13. Phage Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hybridoma: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Transgenic Animal: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Yeast Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Single Cell: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 19. Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 25. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Antibody Discovery Market